Latest Subscription Models News

Mach7 Technologies Limited reported a 16% revenue increase to AUD 33.8 million for FY25, alongside a 22% reduction in net loss, driven by a strategic shift to subscription-based sales and disciplined cost management.

hipages Group reported a robust FY25 with revenue up 10%, EBITDA rising 20%, and free cash flow surging 162%, underpinned by strategic platform migration and subscription model shifts.

hipages Group has delivered a strong FY25 performance, achieving key strategic milestones and robust financial growth, setting the stage for continued momentum in FY26.

hipages Group reported a 10% revenue increase for FY25, driven by strong SaaS platform adoption and operational efficiencies, despite a 33% net profit decline influenced by prior year gains.

Objective Corporation reported solid FY2025 results with 5% revenue growth and a 15% jump in Annualised Recurring Revenue, underpinned by significant R&D investment and a strong subscription model.

WOTSO’s FY25 results reveal a robust 14% increase in underlying EBITDA, driven by its expanding flexible workspace portfolio now spanning 31 locations. Strategic investments and partnerships underpin a confident outlook toward $58 million revenue by FY30.

FirstWave Cloud Technology is launching its first AI-powered compliance management feature for Open-AudIT, aiming to convert a large base of free users into paying customers through a subscription model integrated with AWS.

DroneShield launches SentryCiv, a subscription-based AI-powered counter-drone solution designed to protect civilian critical infrastructure from emerging aerial threats.

Cardiex reported strong growth in its Pulse arterial health monitor sales during Q4 FY25, surpassing A$0.7 million for the year and advancing its transition to subscription-based digital health services.

Aspermont Limited reports a 7% revenue increase driven by subscription growth and a landmark contract with a top global mining company, while preparing to launch new data products.

Spacetalk Ltd reports robust growth in paid mobile subscribers and recurring revenue for Q4 FY25, supported by strategic capital raises and international expansion.

ImpediMed has doubled its US unit sales in Q4 FY25, achieving a record total contract value and securing an additional $5 million tranche under its growth capital facility.